E

Evofem Biosciences Inc
F:1AQ1

Watchlist Manager
Evofem Biosciences Inc
F:1AQ1
Watchlist
Price: 0.1432 EUR -2.59% Market Closed
Market Cap: 65.8m EUR

Wall Street
Price Targets

1AQ1 Price Targets Summary
Evofem Biosciences Inc

There are no price targets for 1AQ1.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
Evofem Biosciences Inc Competitors:
Price Targets
4516
Nippon Shinyaku Co Ltd
3% Upside
600436
Zhangzhou Pientzehuang Pharmaceutical Co Ltd
36% Upside
2070
Saudi Pharmaceutical Industries and Medical Appliances Corporation SJSC
11% Upside
JUBLPHARMA
Jubilant Pharmova Ltd
30% Upside
002653
Haisco Pharmaceutical Group Co Ltd
80% Upside
4506
Sumitomo Pharma Co Ltd
10% Downside

Revenue
Forecast

Revenue Estimate
Evofem Biosciences Inc

For the last 2 years the compound annual growth rate for Evofem Biosciences Inc's revenue is 49%. The projected CAGR for the next 1 year is 599%.

49%
Past Growth
599%
Estimated Growth
Estimates Accuracy
-4%
Average Miss

Operating Income
Forecast

Operating Income Estimate
Evofem Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
0%
Average Beat

Net Income
Forecast

Net Income Estimate
Evofem Biosciences Inc

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
N/A
Average
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is 1AQ1's stock price target?
Not Available

1AQ1 doesn't have any price targets made by Wall Street professionals.

What is Evofem Biosciences Inc's Revenue forecast?
Projected CAGR
599%

For the last 2 years the compound annual growth rate for Evofem Biosciences Inc's revenue is 49%. The projected CAGR for the next 1 year is 599%.

Back to Top